# Dendreon Pharmaceuticals LLC - Inspection Records

Source: https://www.globalkeysolutions.net/companies/dendreon-pharmaceuticals-llc/3de4a8e5-8e34-4212-8862-ecd5256c6ffe

> Inspection records and compliance data for Dendreon Pharmaceuticals LLC in Union City, Georgia. Access full analysis and detailed observations.

---

## Details

- Name: Dendreon Pharmaceuticals LLC
- FEI Number: 3008914686
- City: Union City
- State: Georgia
- Country Name: United States
- Address Line 1: 6715 Oakley Industrial Blvd
- Zip Code: 30291

## Related Documents

- [FDA Inspection 1286816 - Dendreon Pharmaceuticals LLC - 2025-10-29](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/7b3579a1-1d37-40bc-8b3f-16301d44a749) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2025
- [483 - Dendreon Pharmaceuticals LLC - 2022-04-21](https://www.globalkeysolutions.net/records/483/dendreon-pharmaceuticals-llc/25a116c3-0c75-49e3-a561-9f023a1b9016) — source: FDA, date: April 21, 2022
- [FDA Inspection 1169722 - Dendreon Pharmaceuticals LLC - 2022-04-21](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/93960652-a112-4468-ab29-2dcdbc9fb9a2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2022
- [483 - Dendreon Pharmaceuticals LLC - 2018-10-22](https://www.globalkeysolutions.net/records/483/dendreon-pharmaceuticals-llc/a4c2e9e4-ef11-46c5-89bc-9f9f39b154b3) — source: FDA, date: October 22, 2018
- [FDA Inspection 1070321 - Dendreon Pharmaceuticals LLC - 2018-10-22](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/e8e5b54b-3f67-4a9a-85a5-849f625ada54) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2018
- [FDA Inspection 1031496 - Dendreon Pharmaceuticals LLC - 2016-11-01](https://www.globalkeysolutions.net/records/fda_inspections/dendreon-pharmaceuticals-llc/2023ed60-8b86-4221-9226-16ab7b43659f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2016
- [483 - Dendreon Pharmaceuticals LLC - 2015-01-09](https://www.globalkeysolutions.net/records/483/dendreon-pharmaceuticals-llc/822eb493-a842-4f0e-af97-b9c9dd995417) — source: FDA, date: January 9, 2015

## Related Companies

- [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [NATCO Pharma Limited](https://www.globalkeysolutions.net/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Gland Pharma Limited, Units I+II Pashamylaram Site](https://www.globalkeysolutions.net/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca)
- [Glenmark Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d)
- [MassBiologics](https://www.globalkeysolutions.net/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)
- [Glenmark Pharmaceuticals Limited](https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [Nephron Sc Inc](https://www.globalkeysolutions.net/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Charles River Laboratories Inc](https://www.globalkeysolutions.net/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911)
- [Seqirus Inc](https://www.globalkeysolutions.net/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [Mylan Laboratories Limited](https://www.globalkeysolutions.net/companies/mylan-laboratories-limited/b7da9cbd-d5e3-417f-a485-f9e38852b256)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)
- [investigator](https://www.globalkeysolutions.net/people/brantley-s-collins/c806aac1-3d89-4427-8aeb-6d9db6dfc2f4)
